Nuclear receptors are hormone-regulated transcription factors that control many key aspects of normal metazoan reproduction, differentiation, and homeostasis; aberrant nuclear receptors are causal factors in a variety of human endocrine and neoplastic disorders. The ultimate goal of this proposal is to better understand how nuclear receptors participate in signal transduction in normal cells, and the lesions in this process that lead to disease. Many nuclear receptors exhibit bimodal transcriptional properties, and can either repress or activate gene expression. We and others have identified a family of """"""""corepressors"""""""" that physically associate with nuclear receptors, recruit additional proteins, and mediate transcriptional repression. Many signals that impact on nuclear receptor function manifest their effects through changes in corepressor recruitment or function. We propose to continue our research into how the actions of nuclear receptors are mediated through these corepressors. Although focused on repression, aspects of these studies will also touch on the functions of coactivators, and on additional effectors and regulators of nuclear receptor function. Our experiments will address specific aspects of five broad questions:
Specific Aim 1. Why do different nuclear receptor isoforms differ in the ability to interact with corepressor and mediate repression? Specific Aim 2. How does the nature of target DNA influence repression? Specific Aim 3. How does the binding of different hormone ligands regulate repression? Specific Aim 4. How do non-ligand signal transduction pathways regulate repression? Specific Aim 5. How do defects in corepressor function lead to disease? The results from these experiments will contribute to a better understanding of the molecular basis behind nuclear hormone receptor function in both the normal and diseased organism. More broadly., we anticipate that our studies of corepressor action will help clarify the more general phenomenon of eukaryotic transcriptional repression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK053528-05A1S1
Application #
6654317
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1998-04-20
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
5
Fiscal Year
2002
Total Cost
$56,363
Indirect Cost
Name
University of California Davis
Department
Microbiology/Immun/Virology
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Snyder, Chelsea A; Goodson, Michael L; Schroeder, Amy C et al. (2015) Regulation of corepressor alternative mRNA splicing by hormonal and metabolic signaling. Mol Cell Endocrinol 413:228-35
Hahm, Johnnie B; Schroeder, Amy C; Privalsky, Martin L (2014) The two major isoforms of thyroid hormone receptor, TR?1 and TR?1, preferentially partner with distinct panels of auxiliary proteins. Mol Cell Endocrinol 383:80-95
Hahm, Johnnie B; Privalsky, Martin L (2013) Research resource: identification of novel coregulators specific for thyroid hormone receptor-?2. Mol Endocrinol 27:840-59
Mengeling, Brenda J; Goodson, Michael L; Bourguet, William et al. (2012) SMRT?, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors ? and ?. Mol Cell Endocrinol 351:306-16
Lee, Sangho; Young, Briana M; Wan, Wei et al. (2011) A mechanism for pituitary-resistance to thyroid hormone (PRTH) syndrome: a loss in cooperative coactivator contacts by thyroid hormone receptor (TR)beta2. Mol Endocrinol 25:1111-25
Varlakhanova, Natalia; Hahm, Johnnie B; Privalsky, Martin L (2011) Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation. Mol Cell Endocrinol 332:180-8
Mengeling, Brenda J; Phan, Theresa Q; Goodson, Michael L et al. (2011) Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants. J Biol Chem 286:4236-47
Goodson, Michael L; Mengeling, Brenda J; Jonas, Brian A et al. (2011) Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation. J Biol Chem 286:44988-99
Varlakhanova, Natalia; Snyder, Chelsea; Jose, Soumia et al. (2010) Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain. Mol Cell Biol 30:1434-45
Hsia, Elaine Y; Goodson, Michael L; Zou, June X et al. (2010) Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Deliv Rev 62:1227-37

Showing the most recent 10 out of 37 publications